CI · Cigna Group · Documents

May 28

Current report 8-K

Regulation FD disclosure

May 7

Earnings call

Q1 2021 earnings call

May 7

Current report 8-K

Financial results

May 7

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $40.97B ▲ 6.5% Net income $1.17B ▼ 1.5% Diluted EPS $3.30 ▲ 4.8%

May 3

Current report 8-K/A Events of Jan 6

Director or officer change, or executive pay

May 3

Current report 8-K Events of Apr 28

Director or officer change, or executive pay, Shareholder vote results

Apr 30

Current report 8-K Events of Apr 29

Entered into a material agreement, New debt or off-balance-sheet obligation, Other events

Apr 7

Proxy statement DEFA14A

Proxy statement

Mar 19

Proxy statement DEF 14A Meeting Apr 28, 2021

Proxy statement

Mar 19

Proxy statement DEFA14A

Proxy statement

Mar 8

Current report 8-K

Regulation FD disclosure

Mar 3

Current report 8-K Events of Mar 1

Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure, Other events

Feb 26

Current report 8-K

Regulation FD disclosure

Feb 25

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $160.4B ▲ 4.5% Net income $8.49B ▲ 65.8% Diluted EPS $22.96 ▲ 70.8%

Feb 4

Current report 8-K

Financial results

Feb 4

Earnings call

Q4 2020 earnings call

Jan 12

Current report 8-K Events of Jan 6

Director or officer change, or executive pay

Dec 31

Current report 8-K

Regulation FD disclosure

Dec 28

Current report 8-K

Regulation FD disclosure

Dec 11

Current report 8-K Events of Dec 8

Director or officer change, or executive pay

Dec 10

Current report 8-K

Regulation FD disclosure

Nov 30

Current report 8-K

Regulation FD disclosure

Nov 5

Current report 8-K

Financial results

Nov 5

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Revenue $40.96B ▲ 6.2% Net income $1.4B ▲ 3.2% Diluted EPS $3.78 ▲ 5.9%

Nov 5

Earnings call

Q3 2020 earnings call

Oct 30

Current report 8-K Events of Oct 26

Director or officer change, or executive pay

Sep 9

Current report 8-K

Regulation FD disclosure

Aug 20

Current report 8-K

Regulation FD disclosure

Aug 6

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Revenue $39.27B ▲ 1.1% Net income $1.76B ▲ 24.8% Diluted EPS $4.73 ▲ 27.8%

Jul 30

Current report 8-K

Financial results

Jul 30

Earnings call

Q2 2020 earnings call

May 28

Registration statement S-4

Registration statement

May 26

Current report 8-K

Regulation FD disclosure

May 7

Quarterly report 10-Q FY2020 Q1, ended Mar 31

Quarterly report for FY2020 Q1

Revenue $38.47B ▲ 1.4% Net income $1.19B ▼ 13.3% Diluted EPS $3.15 ▼ 11.5%

Apr 30

Current report 8-K

Financial results

Apr 30

Earnings call

Q1 2020 earnings call

Apr 24

Current report 8-K/A Events of Oct 23

Director or officer change, or executive pay

Apr 24

Current report 8-K Events of Apr 22

Shareholder vote results

Apr 6

Proxy statement DEFA14A

Proxy statement

Apr 6

Proxy statement DEFA14A

Proxy statement

Apr 3

Current report 8-K Events of Apr 1

Entered into a material agreement, New debt or off-balance-sheet obligation

Mar 16

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure, Other events

Mar 13

Proxy statement DEF 14A Meeting Apr 22, 2020

Proxy statement

Mar 13

Proxy statement DEFA14A

Proxy statement

Mar 5

Current report 8-K Events of Mar 4

Other events

Mar 4

Registration statement S-3ASR

Registration statement

Feb 27

Current report 8-K Events of Feb 19

Charter or bylaw amendment, or fiscal year change, Regulation FD disclosure, Other events

Feb 27

Annual report 10-K FY2019, ended Dec 31

Annual report for FY2019

Revenue $153.57B ▲ 215.7% Net income $5.12B ▲ 93.5% Diluted EPS $13.44 ▲ 27.5%

Feb 19

Current report 8-K Events of Feb 14

Regulation FD disclosure

Feb 6

Current report 8-K

Financial results